M. Gray-Goodrich

The ras oncogene-mediated sensitization of human cells to topoisomerase II inhibitor-induced apoptosis.

Y. Pommier, A. Monks, K. Paull, 1999, Journal of the National Cancer Institute.

Enhanced sensitivity to 1-beta-D-arabinofuranosylcytosine and topoisomerase II inhibitors in tumor cell lines harboring activated ras oncogenes.

W G Alvord, L V Rubinstein, K D Paull, 1996, Cancer research.

Feasibility of a high-flux anticancer drug screen using a diverse panel of cultured human tumor cell lines.

D. Scudiero, M. Boyd, A. Monks, 1991, Journal of the National Cancer Institute.